Sage Therapeutics
SAGE
#7472
Rank
$0.29 B
Marketcap
$4.78
Share price
-6.27%
Change (1 day)
-75.76%
Change (1 year)

Revenue for Sage Therapeutics (SAGE)

Revenue in 2024 (TTM): $0.10 Billion USD

According to Sage Therapeutics 's latest financial reports the company's current revenue (TTM ) is $0.10 Billion USD. In 2023 the company made a revenue of $86.45 Million USD an increase over the revenue in the year 2022 that were of $7.68 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sage Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.10 B23.07%
2023 $86.45 M1024.7%
2022 $7.68 M21.86%
2021 $6.3 M-99.43%
2020 $1.11 B16123.06%
2019 $6.86 M-92.39%
2018 $90.27 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.25 B 142.06%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.64 B 3,325.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.31 B 198.58%๐Ÿ‡บ๐Ÿ‡ธ USA